CellaVision AB: Notice of 2018 Annual General Meeting of CellaVision (publ)

2018-04-04 - English

The shareholders in CellaVision AB are hereby summoned to the Annual General Meeting, to be held on May 4, 2018 at 15.00 at CellaVision AB, Mobilvägen 12, Ideon in Lund, Sweden. Registration begins at 14:30.

The complete notice is available in Swedish only.

For more information, please contact:
Zlatko Rihter, CEO, CellaVision AB
Phone: +46 733 62 11 06 | E-mail: zlatko.rihter@cellavision.com

About CellaVision
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. Sales are via global partners with support from the mother company in Lund and by the market support organizations in the US, Canada, China, Japan, Dubai, Korea, Australia, France, Germany, Brazil and Great Britain. 
In 2017 sales were SEK 309 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq Stockholm, Mid Cap list. Read more at www.cellavision.com

PDF version: Notice Annual General Meeting 2018 (Swedish)

Subscribe to updates

It's possible to subscribe to CellaVision's press releases, financial information by e-mail and SMS.

Click here to register


Information request

Are you looking for some particular information about our company or our business?

Click here to get in touch


Analyst

ABG Sundal Collier AB
Sten Gustafsson
+46 8 566 286 93

Pareto Securities AB
Christian Lee
+46 8 402 52 67

 

Access our Student Resources

To access this resource, please provide the following information about yourself.